RIA
GSK icon

Realta Investment Advisors’s GSK GSK Stock Holding History

Realta Investment Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5,344
Closed -$229K – 797
2024
Q1 		$229K Sell
5,344
-346
-6% -$14.3K 0.05% 376
2023
Q4 		$211K Sell
5,690
-2,098
-27% -$75.3K 0.05% 402
2023
Q3 		$278K Hold
7,788
– – 0.06% 310
2023
Q2 		$278K Sell
7,788
-931
-11% -$33.4K 0.06% 320
2023
Q1 		$310K Sell
8,719
-1,971
-18% -$69K 0.08% 284
2022
Q4 		$376K Buy
10,690
+462
+5% +$15.4K 0.09% 254
2022
Q3 		$301K Sell
10,228
-1,650
-14% -$62.5K 0.08% 280
2022
Q2 		$650K Buy
11,878
+201
+2% +$11.1K 0.16% 150
2022
Q1 		$636K Buy
11,677
+1,961
+20% +$107K 0.13% 180
2021
Q4 		$536K Buy
9,716
+3,151
+48% +$164K 0.12% 202
2021
Q3 		$314K Sell
6,565
-232
-3% -$11.7K 0.07% 287
2021
Q2 		$338K Sell
6,797
-681
-9% -$32.7K 0.08% 265
2021
Q1 		$334K Sell
7,478
-140
-2% -$6.35K 0.09% 259
2020
Q4 		$350K Sell
7,618
-1,708
-18% -$78.5K 0.1% 221
2020
Q3 		$439K Sell
9,326
-1,416
-13% -$70.9K 0.15% 170
2020
Q2 		$548K Sell
10,742
-1,168
-10% -$59.9K 0.18% 144
2020
Q1 		$564K Sell
11,910
-1,562
-12% -$83.3K 0.24% 114
2019
Q4 		$775K Buy
13,472
+1,175
+10% +$65.4K 0.21% 110
2019
Q3 		$655K Sell
12,297
-308
-2% -$15.8K 0.18% 129
2019
Q2 		$630K Buy
12,605
+729
+6% +$36.6K 0.17% 144
2019
Q1 		$613K Buy
+11,876
New +$593K 0.28% 111

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Realta Investment Advisors's GSK Position: Q2 2024 in Review

Realta Investment Advisors sold out of GSK (GSK) in Q2 2024, closing a stake of 5,344 shares — an estimated $229K sold.

Realta Investment Advisors first reported a position in GSK in Q1 2019 and held it in 21 quarters. The position peaked at $775K in Q4 2019. 884 funds tracked by Wall St. Rank hold GSK as of Q2 2024.

  • Realta Investment Advisors reported no remaining GSK position as of Q2 2024 after selling out during the quarter.
  • Realta Investment Advisors sold 5,344 GSK shares in Q2 2024, an estimated $229K.
  • Realta Investment Advisors first reported a position in GSK in Q1 2019 and held it in 21 quarters.
  • Realta Investment Advisors's GSK position peaked at $775K in Q4 2019.
  • 884 funds tracked by Wall St. Rank held GSK as of Q2 2024.

Based on Realta Investment Advisors's 13F filing for Q2 2024, filed 15 Jul 2024.